BofA Securities made an adjustment to the price target for Altria stock, bringing it down to $61 from the previous $65, while still maintaining a Buy rating on the shares. This change was announced by ...

The Food and Drug Administration’s approval of low-risk tobacco pouches is welcome, but why did it delay for more than four ...

Altria Group stock dipped in Thursday morning trading after the maker of Marlboro cigarettes reported fourth-quarter and full-year earnings that matched analysts’ estimates. Shares of Altria Group ...

The main reason Altria stock pulled back was its guidance came up short. Management said adjusted earnings per share would grow 2% to 5%, reaching $5.22 to $5.37, which compares to the analyst ...